Survey notes increase of orphan-drug designations by the FDA

01/20/2010 | MSNBC

A survey by Tufts University found that the number of treatments that received orphan-drug designation from the FDA increased from 208 products between 2000 and 2002 to 425 between 2006 and 2008. The data highlight pharmaceutical companies' growing interest in drugs for rare diseases, according to the study.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC